5JZS | date | ![]() |
|||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | |||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | |||||||||||||
ligand | FGZ | enzyme |
| ||||||||||||
Gene | AFL40 ; BN1213 ; BN1303 ; ERS007661 ; ERS007663 ; ERS007665 ; ERS007670 ; ERS007679 ; ERS007722 ; ERS007741 ; ERS013471 ; ERS024213 ; ERS027646 ; ERS027654 ; ERS027656 ; ERS027661 ; ERS124361 | ||||||||||||||
Gene Ontology ![]() |
| ||||||||||||||
Primary reference | Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach., Ryan A, Polycarpou E, Lack NA, Evangelopoulos D, Sieg C, Halman A, Bhakta S, Eleftheriadou O, McHugh TD, Keany S, Lowe ED, Ballet R, Abuhammad A, Jacobs WR Jr, Ciulli A, Sim E, Br J Pharmacol. 2017 Apr 5. doi: 10.1111/bph.13810. PMID:28380256 |
Data retrieval |
![]() |
View 5JZS in 3D |
![]() |
Structure-derived information |
Sequence-derived information |
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |